TP-38

DRUG2 trials

Sponsors

Teva Branded Pharmaceutical Products R&D, Inc.

Conditions

Glioblastoma MultiformeRecurrent Glioblastoma Multiforme

Phase 2

Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors

CompletedNCT00071539

Teva Branded Pharmaceutical Products R&D, Inc.Recurrent Glioblastoma Multiforme

Start: 2003-10-31End: 2006-07-31Updated: 2012-01-20

Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors

CompletedNCT00104091

Teva Branded Pharmaceutical Products R&D, Inc.Glioblastoma Multiforme

Start: 2004-12-31End: 2007-06-30Target: 56Updated: 2011-05-23